Speakers & Sessions

Plenary Lectures

Opening Plenary Lecture 1
Renal-Pressure Natriuresis - An Infinite Gain Feedback Mechanism for Long-Term Blood Pressure Regulation?
Keynote Speaker: John E. Hall, USA

Plenary Lecture 2
Disease Genomics and the HapMap Project
Aravinda Chakravarti, USA

Plenary Lecture 3
Proteomics of Renal Exosomes
Mark Knepper, USA

Plenary Lecture 4
The Developmental Origins of Hypertension
David JP Barker, UK

Plenary Lecture 5
Circadian Control of Genes, Cells, and Organs
Ueli Schibler, Switzerland

Moderated Discussion

Salt and Hypertension
Chair: David G. Warnock, USA

• Renal Sodium Handling and Night-Time Blood Pressure
  Michel Burnier, Switzerland
• Ethnic Differences in Proximal and Distal Tubular Sodium Reabsorption in Black and White Populations
  Jan Staessen, Belgium
  
• Effect of Salt Intake on Progression of Chronic Kidney Disease
  Paul Sanders, USA
• Human Hypertension Caused by Mutation in WNK Kinases
  Xavier Jeunemaitre, France

Basic Science Sessions

1. RAAS and Cardiovascular Risk
   Chair: David G. Warnock, USA
   
   
   • Paracrine Factors in Tubuloglomerular Feedback and Renin Secretion
     Jurgen Schnermann, USA
   • ACE2: Linking the RAS to SARS Infections and Amino Acid Metabolism
     Josef M. Penninger, Austria
   • Translational Research Goes Both Ways: Lessons for Basic Biology from Clinical Trials
     John Funder, Australia
     
     
2. Proteinuria and Hypertension
   Chair: Bernard Rossier, Switzerland
   
   
   • Genetics of Steroid-Resistant Nephrotic Syndrome
     Corinne Antignac, France
   • Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria
     Karl Tryggvason, Sweden
   • Chloride Channel Diseases Resulting from Impaired Transepithelial Transport or Vesicular Function
     Thomas Jentsch, Germany
     
     
3. Diuretics Revisited
   Chair: Toshiro Fujita, Japan
   
   
   • Renal Potassium Channels - Implications for Diuretic Use
     Steven C. Hebert, USA
   • The Renal Na-Cl Cotransporter, NCC: a Key Protein in the Regulation of Blood Pressure
     Gerardo Gamba, Mexico
     
   • The Epithelial Sodium Channel ENaC as Drug Target for Diuretics
     Laurent Schild, Switzerland

Clinical Sessions

1. RAAS and Cardiovascular Risk
   Chair: Luis Ruilope, Spain
   
   
   • Improved Assessment of Cardiovascular Risk by Measurements of Office, Home and Ambulatory Blood Pressure
     Giuseppe Mancia, Italy
   • Renin: Friend or Foe?
     Morris Brown, UK
     
   • Endothelial Function and Dysfunction: Testing and Clinical Relevance
     Ton Rabelink, The Netherlands
     
     
2. Proteinuria and Hypertension
   Chair: Morris Brown, UK
   
   
   • The Meaning of Albuminuria in Essential Hypertension
     Luis Ruilope, Spain
     
   • Aldosterone as Proteinuric and Cardiovascular Risk in Metabolic Syndrome - From Bench to Clinic
     Toshiro Fujita, Japan
     
   • Albuminuria, a Separate Target for Treatment in Hypertension
     Dick de Zeeuw, The Netherlands
     
     
3. Diuretics Revisited
   Chair: Jan Staessen, Belgium
   
   
   • Genetic Modulation of Dietary on Pharmacologic Sodium Restriction
     David Geller, USA
     
   • Inhibition of ENaC in Antihypertensive Treatment
     J. Howard Pratt, USA
     
   • Long-Term Effects of Spironolactone in Patients with Chronic Renal Dysfunction
     Vito Campese, USA

Translational Sessions

1. Guyton’s Concept 2007
   
   
   • Linking Genomic Pathways to Complex Guytonian Model Systems of Cardiovascular Function
     Allen Cowley, USA
     
   • A Critical Role for Renal Angiotensin Receptors in the Pathogenesis of Hypertension
     Thomas Coffman, USA
   • Blood Pressure Control - Special Role of ENaC and Body Fluids
     Bernard Rossier, Switzerland
     
     
2. Salt - Regulating Effectors
   Chair: George Bakris, USA
   
   
   • Neural Regulation of Renal Tubular Sodium Reabsorption
     Gerald DiBona, USA
     
   • Renalase is a Novel Monoamine Oxidase that Regulates Cardiac Function and Blood Pressure
     Gary V. Desir, USA
     
   • Oxidative Stress and Nitric Oxide Deficiency in the Kidney: a Critical Link to Hypertension?
     Christopher Wilcox, USA
     
     
3. New Methods and Directions
   Chair: John Funder, Australia
   
   
   • NMR Fragment Screening: Tackling Protein-Protein Interaction Targets
     Hartmut Oschkinat, Germany
     
   • 2-Photon Microscopy of the Kidney: Seeing is Believing
     Bruce Molitoris, USA
     
   • Neural Control of Cardiovascular Function
     David Robertson, USA